Michael Heltzen

Michael Heltzen is an experienced leader in the biotechnology and investment sectors, currently serving as Chief Executive Officer and Chief Strategy Officer at Invizyne, a pioneer in cell-free biomanufacturing. Heltzen is also the Chairman and a key investor at EXO Incubator, focusing on exosome technologies, and has a long history of involvement in private equity and seed investing since 2001. Previous roles include Executive Vice President and CEO at Cardea Bio, where innovative biology-based transistors were developed, and Chairman at BlueSEQ Innovations Inc. Heltzen co-founded Startup City Denmark, contributing to the tech startup ecosystem, and held significant positions at organizations such as BGI Europe and CLC bio. Academic credentials include a degree in Financial Management from Aarhus School of Business and an MBA in Global Entrepreneurship.